Some points from the announcement;
- Commencement of production towards supply of medicinal cannabis to at least 6,000 Australian patients (3,000 from Bundy Site, 3,000 using imported cannabis extract),
- This arrangement is ongoing commencing from Q2 2020,
- Commencement of high CBD dosage clinical trials potentially from Q3 2020. The Southport facility is licensed for production and supply of the clinical trial material.
Positive news overall.
Ann: Production commenced to support 6000 Australian Patients, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.954M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EPN (ASX) Chart |
Day chart unavailable